Eli Lilly Could Swing Over $76 Billion In Value After Earnings

Earnings season will likely keep the tape jumpy this week, and the options market is already sketching out where the biggest post-print air pockets — and upside gaps — could show up, according to Pro.

This is a -selected watchlist that runs from large-cap healthcare to high-beta software and storage names.

The marquee name on the list is Eli Lilly, but the largest implied move is saved for the final section as the countdown runs from the least volatile setup to the most.

9.

Gilead Sciences | Mkt Cap: $161B | Implied Move: 6.72% Gilead Sciences Inc. (NASDAQ: GILD ) reports second quarter of 2026 results on Tuesday, after the closing bell.

Wall Street is looking for a $7.14 per share loss on revenue of $7.40 billion, versus $2.01 in earnings per share on $7.08 billion a year ago — a setup that puts extra weight on the company’s commentary around what’s driving the swing.

Pro data show options are pricing in a 6.72% move, with $10.8 billion of market value at stake given Gilead Sciences’ $161 billion market cap.

Gilead Sciences sells therapies for life-threatening infectious diseases, with a core focus on HIV and hepatitis B and C.

The stock carries a Buy consensus rating, and the stock is trading below the 180-day average analyst price forecast; in July, Morgan Stanley reiterated its Overweight rating and cut its price forecast, while Leerink Partners downgraded the stock to Market Perform and cut its price forecast.

Shares have rallied in 2026, up 8.0% year-to-date, but trade 1.7% below the 200-day moving average after the 50-day moving average crossed below the 200-day in July.

The shares sit about 18% below the 52-week high of $157.29.

Read Also: Apple Underestimated Its Own Customers: AAPL CEO Tim Cook Blames 'Demand Forecast Issue' for Q4 Supply Bottlenecks 8.

Uber | Mkt Cap: $144B | Implied Move: 6.83% Uber Technologies, Inc. (NYSE: UBER ) reports second quarter of 2026 results on Wednesday, before the opening bell.

Consensus estimates call for 83 cents in earnings per share on revenue of $14.24 billion, up from 63 cents on $12.65 billion in the prior-year quarter.

With a platform business that can show operating leverage quickly, investors tend to focus on whether growth and profitability are moving in sync.

According to Pro, the options market is implying a 6.83% move, representing about $9.82 billion of market value at stake for Uber Technologies’ $144 billion market cap.

Uber Technologies matches riders with drivers, diners with restaurants and couriers, and shippers with carriers — and that mix can make the quarter’s segment-level momentum and outlook as important as the headline beat or miss.

The stock has a Buy consensus rating, and the share price sits well below the 180-day average analyst price forecast; in July, B of A Securities reiterated its Buy rating and cut its price forecast, while TD Cowen reiterated its Buy rating.

The stock has pulled back in 2026, down 15.1% year-to-date and trading 10.2% below the 200-day moving average.

The shares sit about 31% below the 52-week high of $101.99.

7.

Howmet Aerospace | Mkt Cap: $112B | Implied Move: 6.89% Howmet Aerospace Inc. (NYSE: HWM ) reports second quarter of 2026 results on Thursday, before the opening bell.

Analysts expect $1.24 in earnings per share on revenue of $2.43 billion, compared with 91 cents on $2.05 billion a year ago.

For an engineered-solutions supplier tied to aerospace and transportation demand, the quarter often comes down to execution and the durability of end-market strength.

Pro data show options are pricing in a 6.89% move, putting roughly $7.74 billion of market value at stake based on Howmet Aerospace’s $112 billion market cap.

Howmet Aerospace makes engineered products for aerospace and transportation customers, and investors will be listening for any read-through on production rates and demand.

The stock carries a Buy consensus rating and the 180-day average analyst price forecast is above where the stock trades; in July, RBC Capital, TD Cowen, and Jefferies raised their price forecasts.

Shares have rallied in 2026, up 31% year-to-date and trading 19.1% above the 200-day moving average.

The shares sit about 66% above the 52-week low of $169.45.

6.

Eli Lilly & Co. | Mkt Cap: $1T | Implied Move: 7.37% Eli Lilly & Co. (NYSE: LLY ) reports second quarter of 2026 results on Wednesday, before the opening bell.

The Street is modeling $8.84 in earnings per share on revenue of $20.44 billion, up from $6.31 on $15.56 billion a year ago.

With a large base and big expectations embedded in forecasts, the market’s reaction can hinge on guidance and the cadence of growth more than the quarter’s headline numbers.

According to Pro, options are implying a 7.37% move.

On Eli Lilly’s $1.04 trillion market cap, that’s about $76.4 billion of market value at stake.

Eli Lilly develops drugs across neuroscience, cardiometabolic, cancer and immunology, keeping the focus on both near-term performance and longer-run pipeline confidence.